Health Care: Drugs

Navidea Biopharmaceuticals Inc (NAVB: OTC)

$0.4435 n/a | n/a%
05/25/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 21.97M 13.25M 6.27M 1.13M
Cost of Sales 1.72M 690.38K 241.71K 332.81K
Gross Operating Profit 20.25M 12.56M 6.03M 797.82K
Selling, General, and Administrative Expenses 13.01M 17.26M 15.54M 15.53M
Research & Development 8.88M 12.79M 16.78M 23.71M
Operating Income before D & A (EBITDA) -1.64M -17.49M -26.29M -38.44M
Depreciation & Amortization 579.33K 1.06M 1.34M 1.17M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 2.79M -3.03M -3.88M -1.50M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 552.24K -21.88M -32.04M -41.11M
Interest Expense 14.86M 6.87M 3.69M 2.76M
Pre-Tax Income -14.31M -28.76M -35.73M -43.87M
Income Taxes 0.00 -436.05K 0.00 0.00
Minority Interest -648.00 -855.00 0.00 0.00
Net Income From Continuing Operations -14.31M -28.32M -35.73M -42.70M
Net Income From Discontinued Operations 0.00 758.61K 0.00 0.00
Net Income From Total Operations -14.31M -27.56M -35.73M -42.70M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -14.31M -27.56M -35.73M -42.70M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-14.31M -28.32M -35.73M -42.70M
Preferred Dividends
Net Income Available To Common -14.31M -28.37M -35.73M -42.70M
Basic EPS from Continuing Ops. -0.09 -0.19 -0.24 -0.35
Basic EPS from Discontinued Ops. 0.00 0.01 0.00 0.00
Basic EPS from Total Operations -0.09 -0.18 -0.24 -0.35
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.09 -0.18 -0.24 -0.35
Basic Normalized Net Income/Share -0.09 -0.19 -0.24 -0.35
EPS fr Continuing Ops. -0.09 -0.19 -0.24 -0.35
EPS fr Discontinued Ops 0.00 0.01 0.00 0.00
EPS fr Total Ops. -0.09 -0.18 -0.24 -0.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.09 -0.18 -0.24 -0.35
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.09 -0.19 -0.24 -0.35
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NAVB

Latest NAVB Headlines from TheStreet

More Financial News for NAVB

Press Releases for NAVB

See All Press Releases

Partner Headlines for NAVB

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter